Author

A. M. Szemiel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Ecology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:clinical cohort / trial· 1 Research Focus:genome assembly· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:statistical model· 1 Organism:virus· 1

Frequent Co-Authors

A. Kohl· 2 shared B. J. Willett· 2 shared E. C. Thomson· 2 shared M. E. Stewart· 2 shared A. da Silva Filipe· 1 shared A. H. Patel· 1 shared A. Merits· 1 shared A. Taggart· 1 shared

Activity by Year

2021-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 32 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Kohl

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

An outbreak of Rift Valley fever among peri-urban dairy cattle in northern Tanzania, 2018

W. A. de Glanville, K. J. Allan, J. M. Nyarobi, K. M. Thomas, F. Lankester, T. Kibona, J. R. Claxton, B. Brennan, R. W. Carter, J. A. Crump, J. E. B. Halliday, G. Ladbury, B. T. Mmbaga, F. Mramba, O. M. Nyasebwa, , S. Cleaveland

The paper reports a previously unreported RVF outbreak in peri-urban dairy cattle in northern Tanzania, identifying 14 abortions and viral shedding in milk.

bioRxiv · Sep 15, 2021 · PreprintEcology

COVID-19: A need for new rather than repurposed antiviral drugs.

D. Kovacs, C. Davis, P. Cannon, M. McFarlane, S. M. Rainey, R. Pinto, M. E. Stewart, A. M. Szemiel, A. Taggart, A. Kohl, F. Marra, E. C. Thomson, J. T. Scott

This paper reviews 29 FDA-approved antiviral compounds for COVID-19 treatment, finds limited clinical efficacy of repurposed drugs, and highlights the need for novel antivirals.

bioRxiv · Mar 25, 2021 · PreprintMicrobiology

In vitro evolution of Remdesivir resistance reveals genome plasticity of SARS-CoV-2

A. M. Szemiel, A. Merits, R. J. Orton, O. MacLean, A. Wickenhagen, G. Lieber, R. M. Pinto, M. L. Turnbull, S. Wang, D. Mair, A. da Silva Filipe, B. J. Willett, S. J. Wilson, A. H. Patel, E. C. Thomson, , M. E. Stewart

This study shows that in vitro evolution of SARS-CoV-2 under remdesivir selects for resistant mutations, but these mutations do not spread widely in global variants.

bioRxiv · Feb 1, 2021Microbiology